Cibus, Inc. (CBUS) vs Neuraxis, Inc. (NRXS)
- Cibus, Inc. CBUS 1.32 +2.33%
- Neuraxis, Inc. NRXS 7.70 −0.52%
Cibus, Inc. and Neuraxis, Inc. are both Biotechnology companies. Cibus, Inc. and Neuraxis, Inc. are of similar size ($98.6M and $97.2M). Neuraxis, Inc. grew revenue faster over the last twelve months: 65.2% against −10.3%. Neuraxis, Inc. has the higher net margin (−159.0% vs −2,258.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 17 metrics below, Neuraxis, Inc. leads on 12 and Cibus, Inc. on 5.
Valuation
Profitability
| Metric | CBUS | NRXS | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 85.56% | 65.16% |
| Operating margin | (1,450.59%) | (144.51%) | 0.00% |
| Net margin | (2,258.89%) | (159.01%) | 0.00% |
| Free cash flow margin | (1,064.60%) | (106.10%) | 0.00% |
| Return on equity | (219.97%) | (153.96%) | (56.36%) |
| Return on assets | (29.77%) | (98.96%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack